SARS-CoV-2 diagnostic workflow with the GenoXtract® fleXT and the FluoroCycler® XT

Dr. Colleen Monaghan will present Hain Lifescience IVD workflows for the latest SARS-CoV-2 diagnostic assays. Rapid response to diagnostic capabilities is essential during these pandemic times. At Bruker-Hain a number of assays have been developed, including FluoroType^® SARS-CoV-2 plus, FluoroType^® SARS-CoV-2 varID Q, FluoroType^® SARS-CoV-2/Flu/RSV, FluoroType^® SARS-CoV-2 evo (RUO), which are essential to faciliate the continuous urgent response to the Covid-19 pandemic and for detection of variants in this highly dynamic situation. Accurate, reliable and efficient diagnostics are the essence of the Bruker-Hain offering. For this reason, we do not stop at the supply of world-leading assays but provide top-class instrumentation to ensure that the accuracy and efficiency is matched. The GenoXtract^® fleXT is a fast, easy to use extraction device, which, with its PCR setup capabilities carefully balances the need for a maximum walk away time with flexibility of use and minimum hands-on time. Finally, the renowned FluoroCycler^® XT, with simple, intuitive software, is easy to use and generates reliable and easy-to-interpret results.

 

Learning Objectives:

FluoroType^® SARS-CoV-2 evo (RUO) is For Research Use Only. Not for use in clinical diagnostic procedures. All other mentioned products are IVD products and are not for sale in the USA. Please contact your local representative for availability in your country

 

Join us for our other webinars in this series: